SHARPIN
Basic information
Region (hg38): 8:144098633-144108124
Links
Phenotypes
GenCC
Source:
- autoinflammation with episodic fever and immune dysregulation (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Autoinflammation with episodic fever and immune dysregulation | AR | Allergy/Immunology/Infectious | The condition involves autoinflammation, with signs of immunodeficiency, and medical management (eg, with TNF inhibitors, IVIG, and corticosteroids) has been described as beneficial | Allergy/Immunology/Infectious | 38609546 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (65 variants)
- not_provided (3 variants)
- Autoinflammation_with_episodic_fever_and_immune_dysregulation (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SHARPIN gene is commonly pathogenic or not. These statistics are base on transcript: NM_000030974.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 60 | 65 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 2 | 0 | 60 | 6 | 0 |
Highest pathogenic variant AF is 6.8437555e-7
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SHARPIN | protein_coding | protein_coding | ENST00000398712 | 8 | 9492 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0000231 | 0.919 | 124780 | 0 | 16 | 124796 | 0.0000641 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.0439 | 215 | 213 | 1.01 | 0.0000118 | 2361 |
| Missense in Polyphen | 53 | 61.239 | 0.86546 | 701 | ||
| Synonymous | -1.92 | 116 | 92.5 | 1.25 | 0.00000549 | 871 |
| Loss of Function | 1.63 | 10 | 17.3 | 0.577 | 8.17e-7 | 184 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000131 | 0.000131 |
| Ashkenazi Jewish | 0.0000998 | 0.0000993 |
| East Asian | 0.000111 | 0.000111 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000626 | 0.0000618 |
| Middle Eastern | 0.000111 | 0.000111 |
| South Asian | 0.000104 | 0.0000980 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the LUBAC complex which conjugates linear polyubiquitin chains in a head-to-tail manner to substrates and plays a key role in NF-kappa-B activation and regulation of inflammation. LUBAC conjugates linear polyubiquitin to IKBKG and RIPK1 and is involved in activation of the canonical NF-kappa-B and the JNK signaling pathways. Linear ubiquitination mediated by the LUBAC complex interferes with TNF-induced cell death and thereby prevents inflammation. LUBAC is recruited to the TNF-R1 signaling complex (TNF-RSC) following polyubiquitination of TNF- RSC components by BIRC2 and/or BIRC3 and to conjugate linear polyubiquitin to IKBKG and possibly other components contributing to the stability of the complex. Together with OTULIN, the LUBAC complex regulates the canonical Wnt signaling during angiogenesis. {ECO:0000269|PubMed:21455173, ECO:0000269|PubMed:21455180, ECO:0000269|PubMed:21455181}.;
- Pathway
- Necroptosis - Homo sapiens (human);NOD-like receptor signaling pathway - Homo sapiens (human);Signal Transduction;Neuronal System;TNFR1-induced NFkappaB signaling pathway;TNF signaling;Death Receptor Signalling;Regulation of TNFR1 signaling;Neurexins and neuroligins;Protein-protein interactions at synapses
(Consensus)
Recessive Scores
- pRec
- 0.0834
Intolerance Scores
- loftool
- 0.359
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 61.91
Haploinsufficiency Scores
- pHI
- 0.0677
- hipred
- N
- hipred_score
- 0.432
- ghis
- 0.390
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.922
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sharpin
- Phenotype
- digestive/alimentary phenotype; vision/eye phenotype; immune system phenotype; skeleton phenotype; respiratory system phenotype; liver/biliary system phenotype; reproductive system phenotype; normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- mitochondrion organization;I-kappaB kinase/NF-kappaB signaling;brain development;regulation of tumor necrosis factor-mediated signaling pathway;apoptotic nuclear changes;keratinization;positive regulation of I-kappaB kinase/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;negative regulation of inflammatory response;protein homooligomerization;protein linear polyubiquitination;regulation of CD40 signaling pathway
- Cellular component
- cytosol;postsynaptic density;cell junction;dendrite;LUBAC complex
- Molecular function
- ubiquitin-protein transferase activity;protein binding;polyubiquitin modification-dependent protein binding;identical protein binding;ubiquitin binding;protein-containing complex binding;metal ion binding